Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.465
-0.050 (-1.99%)
Sep 24, 2026, 12:20 PM EDT - Market open
Genelux Market Cap
Genelux has a market cap or net worth of $110.46 million as of September 24, 2026. Its market cap has decreased by -28.89% in one year.
Market Cap
110.46M
Enterprise Value
94.21M
1-Year Change
-28.89%
Ranking
Category
Stock Price
$2.47
ChartMarket Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $110.46M, a decrease of -22.04%. That is a compound annual growth rate of -6.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 116.96M | -28.69% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biomea Fusion | 123.22M |
| Equillium | 122.38M |
| ProMIS Neurosciences | 121.78M |
| Cibus | 121.52M |
| Cellectis | 115.71M |
| Tiziana Life Sciences | 115.07M |
| Vivani Medical | 114.56M |
| PMV Pharmaceuticals | 114.02M |